As of 2025-09-17, the Fair Value of Stayble Therapeutics AB (STABL.ST) is -0.96 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.30 SEK, the upside of Stayble Therapeutics AB is -421.57%.
With the market price of 0.30 SEK and our fair value calculation, Stayble Therapeutics AB (STABL.ST) is not a good investment. Investing in STABL.ST stocks now will result in a potential loss of 421.57%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -15.49 | -12.09 | -24.53 | -23.74 | -12.42 | -17.65 |
| YoY growth | -109.04% | 21.95% | -102.86% | 3.22% | 47.69% | -27.81% |
| Market Cap (mil) | 19.31 |
| P/E | |
| Forward P/E |
| EPS | -0.19 |
| Avg earnings growth rate | -27.81% |
| TTM earnings | -12.42 |